Schlachetzki JCM - Search Results

1

Author Correction: A monocyte gene expression signature in the early clinical course of Parkinson's disease.

Schlachetzki JCM, Prots I, Tao J, Chun HB, Saijo K, Gosselin D, Winner B, Glass CK, Winkler J. Schlachetzki JCM, et al. Sci Rep. 2020 Apr 7;10(1):6261. doi: 10.1038/s41598-020-62928-6. Sci Rep. 2020. PMID: 32253373 Free PMC article.

2

Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.

Xiang W, Schlachetzki JC, Helling S, Bussmann JC, Berlinghof M, Schäffer TE, Marcus K, Winkler J, Klucken J, Becker CM. Xiang W, et al. Mol Cell Neurosci. 2013 May;54:71-83. doi: 10.1016/j.mcn.2013.01.004. Epub 2013 Jan 28. Mol Cell Neurosci. 2013. PMID: 23369945

3

Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease.

Schlachetzki JC, Marxreiter F, Regensburger M, Kulinich A, Winner B, Winkler J. Schlachetzki JC, et al. Restor Neurol Neurosci. 2014;32(4):447-62. doi: 10.3233/RNN-130371. Restor Neurol Neurosci. 2014. PMID: 24604006

4

Intracerebroventricular administration of nerve growth factor induces gliogenesis in sensory ganglia, dorsal root, and within the dorsal root entry zone.

Schlachetzki JC, Pizzo DP, Morrissette DA, Winkler J. Schlachetzki JC, et al. Biomed Res Int. 2014;2014:704259. doi: 10.1155/2014/704259. Epub 2014 Mar 16. Biomed Res Int. 2014. PMID: 24738070 Free PMC article.

5

Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells.

Ettle B, Reiprich S, Deusser J, Schlachetzki JC, Xiang W, Prots I, Masliah E, Winner B, Wegner M, Winkler J. Ettle B, et al. Mol Cell Neurosci. 2014 Sep;62:68-78. doi: 10.1016/j.mcn.2014.06.012. Epub 2014 Jul 11. Mol Cell Neurosci. 2014. PMID: 25019582 Free PMC article.

6

Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.

Xiang W, Menges S, Schlachetzki JC, Meixner H, Hoffmann AC, Schlötzer-Schrehardt U, Becker CM, Winkler J, Klucken J. Xiang W, et al. Mol Neurodegener. 2015 Mar 11;10:8. doi: 10.1186/s13024-015-0004-0. Mol Neurodegener. 2015. PMID: 25886189 Free PMC article.

7

Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?

Ettle B, Schlachetzki JCM, Winkler J. Ettle B, et al. Among authors: schlachetzki jcm. Mol Neurobiol. 2016 Jul;53(5):3046-3062. doi: 10.1007/s12035-015-9205-3. Epub 2015 May 13. Mol Neurobiol. 2016. PMID: 25966971 Free PMC article. Review.

8

Hippocampal structure and function are maintained despite severe innate peripheral inflammation.

Süß P, Kalinichenko L, Baum W, Reichel M, Kornhuber J, Loskarn S, Ettle B, Distler JH, Schett G, Winkler J, Müller CP, Schlachetzki JC. Süß P, et al. Brain Behav Immun. 2015 Oct;49:156-70. doi: 10.1016/j.bbi.2015.05.011. Epub 2015 Jun 12. Brain Behav Immun. 2015. PMID: 26074461

9

The innate immune system in Parkinson's disease: a novel target promoting endogenous neuroregeneration.

Schlachetzki JC, Winkler J. Schlachetzki JC, et al. Neural Regen Res. 2015 May;10(5):704-6. doi: 10.4103/1673-5374.156958. Neural Regen Res. 2015. PMID: 26109939 Free PMC article. No abstract available.

10

Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of α-synuclein.

Schlachetzki JC, Grimm T, Schlachetzki Z, Ben Abdallah NM, Ettle B, Vöhringer P, Ferger B, Winner B, Nuber S, Winkler J. Schlachetzki JC, et al. J Neurosci Res. 2016 Jan;94(1):62-73. doi: 10.1002/jnr.23677. Epub 2015 Oct 9. J Neurosci Res. 2016. PMID: 26451750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters